Our network has expanded. PCRN have joined us and rebranded to Momentum Clinical Research.
- Home
- Clinical Trials
Type 2 Diabetes Studies Brisbane TA 63
Type 2 Diabetes Study
Taringa Brisbane
Please note that this study has now closed. However, we encourage you to pre-register your interest for future Type 2 Diabetes studies here.
Description
What to expect
Study details
Ages
18 to 65 years old
Duration
The study has a duration of approximately 20 weeks, and involves up to 11 clinic visits
Compensation
Eligible participants will receive all study-related care at no cost and will be compensated for reasonable expenses associated with study visits
Eligibility Criteria
You may qualify if you:
- Are 18 to 65 years old
- Have been diagnosed for Type 2 Diabetes Mellitus for at least 5 years
- Are taking up to 3 antidiabetic medications (not including insulin) at a stable dose for at least the past 3 months
Please note, potential participants who have used insulin or weight loss medication in the last 3-months will not be eligible for this study.
Other criteria applies. A member of our team will check if this study is a good fit for you.
Locations
Description
Type 2 Diabetes (T2DM) is a common, long-term condition that affects how the body regulates and uses sugar (glucose) for energy. In people with Type 2 Diabetes, the body either doesn’t produce enough insulin or can’t use it effectively, causing blood sugar levels to rise. Over time, these higher sugar levels can damage blood vessels and organs, increasing the risk of serious health problems such as heart disease, stroke, nerve damage, vision changes and kidney disease.
Living with Type 2 Diabetes can be challenging. It often means managing blood sugar levels through a combination of healthy eating, regular physical activity, and daily medication. Despite this, many people still find it difficult to keep their blood sugar within the target range, even while taking several diabetes medicines.
This study is testing a potential new oral treatment that targets a protein called menin, which plays a key role in insulin production and glucose regulation. Researchers hope that the investigational treatment may:
- Improve blood sugar control
- Support healthy insulin and hormone responses
- Improve lipid metabolism and body weight measures
- Offer a potential new approach to managing Type 2 Diabetes
What to expect
Participants will be randomly assigned to receive either the investigational medication or a placebo. Both will be taken as capsules, twice daily for 28 days during the treatment period.
You will visit the clinic regularly for health assessments, including blood glucose monitoring and general checkups. Your safety and well-being will be closely monitored by a professional clinical team.
Why join this clinical research study?
- Participate in innovative research exploring new treatment options for Type 2 Diabetes
- Receive regular health checks and advice from our professional medical team
- Contribute to research that may potentially improve future diabetes care
Your privacy is important. All personal information will be kept strictly confidential.
Register your interest today.
This study is now closed
Please note that this study has now closed. However, we encourage you to pre-register your interest for future Type 2 Diabetes studies here.